We are live on ! Find out more
EARNEST Partners

EARNEST Partners Portfolio holdings

AUM $24.3B
1-Year Est. Return 34.41%
This Fund
S&P 500
This Quarter Est. Return
-2.58%
1 Year Est. Return
+34.41%
3 Year Est. Return
+66.51%
5 Year Est. Return
+86.35%
10 Year Est. Return
+426.93%
AUM
$14.9B
AUM Growth
-$125M
Cap. Flow
+$602M
Cap. Flow %
4.04%
Top 10 Hldgs %
16.63%
Holding
1,195
New
6
Increased
170
Reduced
89
Closed
18

Top Buys

Rank Stock Value
1
UCB
United Community Banks
UCB
+$98.2M
2
FLS icon
Flowserve
FLS
+$86.8M
3
SPR
Spirit AeroSystems
SPR
+$82.2M
4
CTS icon
CTS Corp
CTS
+$70M
5
CRL icon
Charles River Laboratories
CRL
+$62.2M

Top Sells

Rank Stock Value
1
VIVO
Meridian Bioscience Inc
VIVO
+$115M
2
MPWR icon
Monolithic Power Systems
MPWR
+$75.3M
3
EBS icon
Emergent Biosolutions
EBS
+$57.3M
4
ON icon
ON Semiconductor
ON
+$28.3M
5
SQM icon
Sociedad Química y Minera de Chile
SQM
+$20.1M

Sector Composition

Rank Sector Weight
1 Financials 20.5%
2 Industrials 19.89%
3 Technology 19.85%
4 Consumer Discretionary 10.32%
5 Healthcare 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGNX icon
951
Cognex
CGNX
$9.62B
$2K ﹤0.01%
60
– –
CLRO icon
952
ClearOne Inc
CLRO
$12M
$2K ﹤0.01%
227
– –
CM icon
953
Canadian Imperial Bank of Commerce
CM
$106B
$2K ﹤0.01%
54
– –
CXT icon
954
Crane NXT
CXT
$2.99B
$2K ﹤0.01%
58
– –
DB icon
955
Deutsche Bank
DB
$66.6B
$2K ﹤0.01%
304
– –
DELL icon
956
Dell
DELL
$239B
$2K ﹤0.01%
72
– –
DVA icon
957
DaVita
DVA
$15.5B
$2K ﹤0.01%
23
– –
DWSN icon
958
Dawson Geophysical
DWSN
$130M
$2K ﹤0.01%
1,262
– –
ELAN icon
959
Elanco Animal Health
ELAN
$13.2B
$2K ﹤0.01%
190
– –
EMBC icon
960
Embecta
EMBC
$218M
$2K ﹤0.01%
85
– –
ESI icon
961
Element Solutions
ESI
$8.48B
$2K ﹤0.01%
110
– –
EW icon
962
Edwards Lifesciences
EW
$49.4B
$2K ﹤0.01%
30
– –
EXAS
963
DELISTED
Exact Sciences
EXAS
$2K ﹤0.01%
64
– –
EXP icon
964
Eagle Materials
EXP
$6.49B
$2K ﹤0.01%
20
– –
FAF icon
965
First American
FAF
$7.98B
$2K ﹤0.01%
46
– –
FL
966
DELISTED
Foot Locker
FL
$2K ﹤0.01%
61
– –
FLR icon
967
Fluor
FLR
$6.54B
$2K ﹤0.01%
86
– –
FOX icon
968
Fox Class B
FOX
$22.1B
$2K ﹤0.01%
83
– –
GHC icon
969
Graham Holdings Company
GHC
$5.31B
$2K ﹤0.01%
3
– –
GIB icon
970
CGI
GIB
$15.4B
$2K ﹤0.01%
21
– –
HLF icon
971
Herbalife
HLF
$1.3B
$2K ﹤0.01%
76
– –
HP icon
972
Helmerich & Payne
HP
$3.34B
$2K ﹤0.01%
54
– –
IBKR icon
973
Interactive Brokers
IBKR
$38.4B
$2K ﹤0.01%
132
– –
IMO icon
974
Imperial Oil
IMO
$62.3B
$2K ﹤0.01%
39
– –
IONS icon
975
Ionis Pharmaceuticals
IONS
$8.93B
$2K ﹤0.01%
49
– –
37 38
39
40 41

Similar funds

JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

EARNEST Partners's Q3 2022 Portfolio in Review

As of Q3 2022, EARNEST Partners held 1,195 positions worth $14.9B, down 0.84% from $15B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

EARNEST Partners deployed $602M of net new capital in Q3 2022, opening 6 new positions and adding to 170 existing holdings. Its largest new stake was CTS Corp: 1,744,320 shares worth $72.7M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Meridian Bioscience Inc, an estimated $115M trimmed.

  • EARNEST Partners's largest Q3 2022 buy was CTS Corp: 1,744,320 shares worth $72.7M.
  • EARNEST Partners added most to United Community Banks in Q3 2022, an estimated $98.2M increase.
  • EARNEST Partners's biggest Q3 2022 reduction was Meridian Bioscience Inc, cutting an estimated $115M.
  • EARNEST Partners fully exited Emergent Biosolutions in Q3 2022, selling an estimated $57.3M.
  • EARNEST Partners's ten largest holdings make up 17% of its $14.9B portfolio in Q3 2022.
  • EARNEST Partners opened 6 new positions and closed 18 in Q3 2022.
  • EARNEST Partners's portfolio value fell 0.84% quarter-over-quarter to $14.9B.

Based on EARNEST Partners's 13F filing for Q3 2022, filed 14 Nov 2022.